(Q38202986)

30 August 2017

title

Metabolic pathology of autism in relation to redox metabolism (English)

1 reference

30 August 2017

0 references

0 references

Richard E Frye

1

1 reference

30 August 2017

S Jill James

series ordinal

2

1 reference

30 August 2017

publication date

1 January 2014

1 reference

30 August 2017

published in

Biomarkers in Medicine

1 reference

30 August 2017

volume

8

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

321-330

1 reference

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Genetics evaluation for the etiologic diagnosis of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Genetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Tetrahydrobiopterin as a novel therapeutic intervention for autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Application of a Ketogenic Diet in Children With Autistic Behavior: Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Extending life span by increasing oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Oxidative stress in synapse development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Selective vulnerability in the developing central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Redox regulation of homocysteine-dependent glutathione synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Oxidative stress-related biomarkers in autism: systematic review and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

A prospective study of transsulfuration biomarkers in autistic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Impaired synthesis and antioxidant defense of glutathione in the cerebellum of autistic subjects: alterations in the activities and protein expression of glutathione-related enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Genetic variant of glutathione peroxidase 1 in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Analysis of case-parent trios at a locus with a deletion allele: association of GSTM1 with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Glutathione pathway gene variation and risk of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Level of trace elements (copper, zinc, magnesium and selenium) and toxic elements (lead and mercury) in the hair and nail of children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

A family history study of schizophrenia spectrum disorders suggests new candidate genes in schizophrenia and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Biomarkers of environmental toxicity and susceptibility in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Preliminary evidence for involvement of the folate gene polymorphism 19bp deletion-DHFR in occurrence of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Cerebral folate receptor autoantibodies in autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Brief report: autistic symptoms, developmental regression, mental retardation, epilepsy, and dyskinesias in CNS folate deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

A milk-free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Autoantibodies to folate receptors in the cerebral folate deficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Cerebral folate deficiency with developmental delay, autism, and response to folinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Fever plus mitochondrial disease could be risk factors for autistic regression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Role of folate receptor autoantibodies in infantile autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Abnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Brain Region-Specific Changes in Oxidative Stress and Neurotrophin Levels in Autism Spectrum Disorders (ASD)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Evidence of reactive oxygen species-mediated damage to mitochondrial DNA in children with typical autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Urinary oxidative stress markers in children with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Examination of tetrahydrobiopterin pathway genes in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Genetic architecture in autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Patterns and rates of exonic de novo mutations in autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

De novo mutations revealed by whole-exome sequencing are strongly associated with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Folate (vitamin B9) and vitamin B12 and their function in the maintenance of nuclear and mitochondrial genome integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Unique association between global DNA hypomethylation and chromosomal alterations in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

A randomized controlled pilot trial of oral N-acetylcysteine in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

A preliminary trial of ascorbic acid as supplemental therapy for autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Redox metabolism abnormalities in autistic children associated with mitochondrial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

Tetrahydrobiopterin as a treatment for autism spectrum disorders: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.158

21 January 2018

Identifiers

DOI

10.2217/BMM.13.158

1 reference

30 August 2017

1 reference